• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清细胞因子水平差异可区分临床肺腺癌和浸润性肺腺癌:一项横断面研究。

Differences in serum cytokine levels distinguish between clinically lung adenocarcinoma and invasive lung adenocarcinoma: A cross-sectional study.

作者信息

Zeng Bingjie, Wang Xianzhao, Qin Yueyang, Cao Leiqun, Zhang Congcong, Meng Fanyu, Chen Changqiang, Wang Jiayi, Ma Lifang

机构信息

Department of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

出版信息

Health Sci Rep. 2023 Sep 8;6(9):e1522. doi: 10.1002/hsr2.1522. eCollection 2023 Sep.

DOI:10.1002/hsr2.1522
PMID:37692791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10486205/
Abstract

BACKGROUND

Lung cancer incidence and mortality remain high and are now the leading cause of cancer-related death. Lung adenocarcinoma (LUAD) is one of the main histological subtypes of lung cancer. Previous studies have shown the role of inflammation in the development of lung cancer, but the relationship between cytokines and LUAD is still unclear. To further differentiate and explore the association of cytokines with the risk of non-invasive and invasive LUAD, we studied and assessed serum cytokine levels in patients with two types of LUAD.

METHODS

A cohort study of 90 non-invasive LUAD and 90 invasive LUAD was retrospectively included, and the clinical characteristics were recorded in detail. The differences in the levels of 12 serum cytokines (IFN-α, IFN-γ, IL-10, IL-12P70, IL-17A, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, and TNF-α) between the two groups of patients with LUAD were analyzed and evaluated. And we evaluated the clinical value of cytokine differential diagnosis of invasive LUAD based on receiver operating characteristics (ROC) curves.

RESULTS

The mean age of the patients was 56.6 years, and the proportions of males and females were 38.9% and 61.1%, respectively. IFN-α, IL-1β, IL-2, IL-6, TNF-α, IL-4, and IL-8 were significantly increased in patients with invasive LUAD compared with the non-invasive LUAD group. Further research found that smoking is an important factor, with changes in the four cytokines IL-1β, IL-6, IL-8, and TNF-α being significantly higher in the smoking group of patients with invasive LUAD. It can be seen from the area under the curve that IL-1β and IL-2 have a significant differential diagnosis.

CONCLUSIONS

We observed differences in preoperative serum cytokine levels between patients with invasive and non-invasive LUAD, which may serve as potential serum biomarkers for clinical differential diagnosis and disease progression assessment.

摘要

背景

肺癌的发病率和死亡率仍然很高,目前是癌症相关死亡的主要原因。肺腺癌(LUAD)是肺癌的主要组织学亚型之一。先前的研究已经表明炎症在肺癌发展中的作用,但细胞因子与LUAD之间的关系仍不清楚。为了进一步区分和探索细胞因子与非侵袭性和侵袭性LUAD风险的关联,我们研究并评估了两种类型LUAD患者的血清细胞因子水平。

方法

回顾性纳入了一项对90例非侵袭性LUAD和90例侵袭性LUAD的队列研究,并详细记录了临床特征。分析并评估了两组LUAD患者之间12种血清细胞因子(IFN-α、IFN-γ、IL-10、IL-12P70、IL-17A、IL-1β、IL-2、IL-4、IL-5、IL-6、IL-8和TNF-α)水平的差异。并且我们基于受试者工作特征(ROC)曲线评估了细胞因子对侵袭性LUAD的鉴别诊断的临床价值。

结果

患者的平均年龄为56.6岁,男性和女性的比例分别为38.9%和61.1%。与非侵袭性LUAD组相比,侵袭性LUAD患者的IFN-α、IL-1β、IL-2、IL-6、TNF-α、IL-4和IL-8显著升高。进一步研究发现吸烟是一个重要因素,侵袭性LUAD患者吸烟组中四种细胞因子IL-1β、IL-6、IL-8和TNF-α的变化明显更高。从曲线下面积可以看出,IL-1β和IL-2具有显著的鉴别诊断价值。

结论

我们观察到侵袭性和非侵袭性LUAD患者术前血清细胞因子水平存在差异,这可能作为临床鉴别诊断和疾病进展评估的潜在血清生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/10486205/d3f0e991aef4/HSR2-6-e1522-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/10486205/dd05ebb9125a/HSR2-6-e1522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/10486205/d3f0e991aef4/HSR2-6-e1522-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/10486205/dd05ebb9125a/HSR2-6-e1522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a6/10486205/d3f0e991aef4/HSR2-6-e1522-g001.jpg

相似文献

1
Differences in serum cytokine levels distinguish between clinically lung adenocarcinoma and invasive lung adenocarcinoma: A cross-sectional study.血清细胞因子水平差异可区分临床肺腺癌和浸润性肺腺癌:一项横断面研究。
Health Sci Rep. 2023 Sep 8;6(9):e1522. doi: 10.1002/hsr2.1522. eCollection 2023 Sep.
2
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.贝切特病口腔溃疡期间的唾液和血清细胞因子谱。
Front Immunol. 2021 Dec 22;12:724900. doi: 10.3389/fimmu.2021.724900. eCollection 2021.
3
The clinical value of IL-3, IL-4, IL-12p70, IL17A, IFN-γ, MIP-1β, NLR, P-selectin, and TNF-α in differentiating bloodstream infections caused by gram-negative, gram-positive bacteria and fungi in hospitalized patients: An Observational Study.IL-3、IL-4、IL-12p70、IL17A、IFN-γ、MIP-1β、中性粒细胞与淋巴细胞比值(NLR)、P-选择素及肿瘤坏死因子-α(TNF-α)在区分住院患者革兰阴性菌、革兰阳性菌及真菌所致血流感染中的临床价值:一项观察性研究
Medicine (Baltimore). 2019 Sep;98(38):e17315. doi: 10.1097/MD.0000000000017315.
4
Potential Impacts of Promoter Polymorphisms on the Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan.台湾地区启动子多态性对非小细胞肺癌突变状态和进展的潜在影响。
Genes (Basel). 2021 Mar 17;12(3):427. doi: 10.3390/genes12030427.
5
Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis.微管蛋白α-1b 作为肺腺癌诊断和预后的潜在生物标志物。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231178391. doi: 10.1177/15330338231178391.
6
Clinical value of serum DJ-1 in lung adenocarcinoma.血清DJ-1在肺腺癌中的临床价值。
PeerJ. 2024 Jan 29;12:e16845. doi: 10.7717/peerj.16845. eCollection 2024.
7
IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway.IL-17A 诱导的癌症相关成纤维细胞通过 Wnt/β-连环蛋白信号通路释放 CXCL12 促进肺腺癌的进展。
Cytokine. 2024 Aug;180:156676. doi: 10.1016/j.cyto.2024.156676. Epub 2024 Jun 9.
8
A predictive model based on ground glass nodule features high-resolution CT for identifying invasiveness of lung adenocarcinoma.基于高分辨率CT磨玻璃结节特征的预测模型用于识别肺腺癌的侵袭性。
Front Surg. 2022 Aug 26;9:973523. doi: 10.3389/fsurg.2022.973523. eCollection 2022.
9
Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients.血清白细胞介素-1β与miR-144-3p的相关性及其在肺腺癌和肺鳞癌患者中的预后价值。
Oncotarget. 2016 Dec 27;7(52):85876-85887. doi: 10.18632/oncotarget.13042.
10
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.非住院轻/中度 COVID-19 感染患者的促炎和抗炎细胞因子的血清谱。
Immunol Lett. 2023 Aug;260:24-34. doi: 10.1016/j.imlet.2023.06.008. Epub 2023 Jun 18.

引用本文的文献

1
Advances in the mechanism of small extracellular vesicles promoting the development of hepatocellular carcinoma through multi-network fusion.小细胞外囊泡通过多网络融合促进肝细胞癌发展的机制研究进展
Front Immunol. 2025 Jul 9;16:1558468. doi: 10.3389/fimmu.2025.1558468. eCollection 2025.
2
Roflumilast reduces the number of lung adenocarcinomas, inflammation, and emphysema in a smoking-induced mouse model.罗氟司特可减少吸烟诱导的小鼠模型中肺腺癌的数量、炎症及肺气肿。
BMC Pulm Med. 2025 May 26;25(1):262. doi: 10.1186/s12890-025-03730-w.
3
Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation.

本文引用的文献

1
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem.鼻咽癌生态学理论:癌症作为多维时空的“生态与进化统一体”病理性生态系统。
Theranostics. 2023 Mar 5;13(5):1607-1631. doi: 10.7150/thno.82690. eCollection 2023.
2
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
3
Single-cell spatial landscapes of the lung tumour immune microenvironment.
伤口愈合:通过炎症和白细胞介素-6调节深入了解自身免疫、衰老和癌症生态系统。
Front Immunol. 2024 Nov 29;15:1403570. doi: 10.3389/fimmu.2024.1403570. eCollection 2024.
肺部肿瘤免疫微环境的单细胞空间景观。
Nature. 2023 Feb;614(7948):548-554. doi: 10.1038/s41586-022-05672-3. Epub 2023 Feb 1.
4
A systematic review examining the relationship between cytokines and cachexia in incurable cancer.系统评价探讨不可治愈癌症中细胞因子与恶病质的关系。
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):824-838. doi: 10.1002/jcsm.12912. Epub 2022 Jan 25.
5
Harnessing cytokines and chemokines for cancer therapy.利用细胞因子和趋化因子进行癌症治疗。
Nat Rev Clin Oncol. 2022 Apr;19(4):237-253. doi: 10.1038/s41571-021-00588-9. Epub 2022 Jan 7.
6
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.2021 年世卫组织肺肿瘤分类:自 2015 年以来的进展影响。
J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20.
7
Inflammation and tumor progression: signaling pathways and targeted intervention.炎症与肿瘤进展:信号通路与靶向干预。
Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5.
8
Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies.肺腺癌谱系病变:检测、病理学和治疗策略。
Cancer Treat Rev. 2021 Sep;99:102237. doi: 10.1016/j.ctrv.2021.102237. Epub 2021 May 29.
9
Interleukin-1 in tumor progression, therapy, and prevention.白细胞介素-1 在肿瘤进展、治疗和预防中的作用。
Cancer Cell. 2021 Aug 9;39(8):1023-1027. doi: 10.1016/j.ccell.2021.04.011. Epub 2021 May 13.
10
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.靶向肿瘤来源的 NLRP3 通过限制 MDSCs 扩增来抑制黑色素瘤进展。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2000915118.